港股異動 | 歐舒丹(0973.HK)漲超6%創新高 將於今日盤後發財報
格隆匯6月28日丨歐舒丹(0973.HK)拉昇漲超6%,報28.85港元再創歷史新高價,總市值達425億港元。歐舒丹將於今日舉行董事會議審批全年業績,並考慮派發末期股息(如有)。公司截至3月底止第四財季,以固定匯率計銷售同比升12.5%,相對於第二及第三財季分別跌4.5%及升4.3%,表現遠勝預期。野村此前將公司2021財年經營溢利率指引上調至逾12%,以反映業務勢頭強勁及經營效益上升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.